A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor.
Exogenous vascular endothelial growth factor (VEGF) accelerates compensatory lung growth (CLG) in mice after unilateral pneumonectomy. In this study, we unexpectedly discovered a method to enhance CLG with a VEGF inhibitor, soluble VEGFR1. Eight-week-old C57BL/6 male mice underwent left pneumonectom...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/1b3d0cc9fe344dfcb85c9aed00b3e2fd |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:1b3d0cc9fe344dfcb85c9aed00b3e2fd |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:1b3d0cc9fe344dfcb85c9aed00b3e2fd2021-12-02T20:18:58ZA paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor.1932-620310.1371/journal.pone.0208579https://doaj.org/article/1b3d0cc9fe344dfcb85c9aed00b3e2fd2018-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0208579https://doaj.org/toc/1932-6203Exogenous vascular endothelial growth factor (VEGF) accelerates compensatory lung growth (CLG) in mice after unilateral pneumonectomy. In this study, we unexpectedly discovered a method to enhance CLG with a VEGF inhibitor, soluble VEGFR1. Eight-week-old C57BL/6 male mice underwent left pneumonectomy, followed by daily intraperitoneal (ip) injection of either saline (control) or 20 μg/kg of VEGFR1-Fc. On post-operative day (POD) 4, mice underwent pulmonary function tests (PFT) and lungs were harvested for volume measurement and analyses of the VEGF signaling pathway. To investigate the role of hypoxia in mediating the effects of VEGFR1, experiments were repeated with concurrent administration of PT-2385, an inhibitor of hypoxia-induced factor (HIF)2α, via orogastric gavage at 10 mg/kg every 12 hours for 4 days. We found that VEGFR1-treated mice had increased total lung capacity (P = 0.006), pulmonary compliance (P = 0.03), and post-euthanasia lung volume (P = 0.049) compared to control mice. VEGFR1 treatment increased pulmonary levels of VEGF (P = 0.008) and VEGFR2 (P = 0.01). It also stimulated endothelial proliferation (P < 0.0001) and enhanced pulmonary surfactant production (P = 0.03). The addition of PT-2385 abolished the increase in lung volume and endothelial proliferation in response to VEGFR1. By paradoxically stimulating angiogenesis and enhancing lung growth, VEGFR1 could represent a new treatment strategy for neonatal lung diseases characterized by dysfunction of the HIF-VEGF pathway.Duy T DaoLorenzo Anez-BustillosSahir S JabbouriAmy PanHiroko KishikawaPaul D MitchellGillian L FellMeredith A BakerRandolph S WatnickHong ChenMichael S RogersDiane R BielenbergMark PuderPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 13, Iss 12, p e0208579 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Duy T Dao Lorenzo Anez-Bustillos Sahir S Jabbouri Amy Pan Hiroko Kishikawa Paul D Mitchell Gillian L Fell Meredith A Baker Randolph S Watnick Hong Chen Michael S Rogers Diane R Bielenberg Mark Puder A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor. |
| description |
Exogenous vascular endothelial growth factor (VEGF) accelerates compensatory lung growth (CLG) in mice after unilateral pneumonectomy. In this study, we unexpectedly discovered a method to enhance CLG with a VEGF inhibitor, soluble VEGFR1. Eight-week-old C57BL/6 male mice underwent left pneumonectomy, followed by daily intraperitoneal (ip) injection of either saline (control) or 20 μg/kg of VEGFR1-Fc. On post-operative day (POD) 4, mice underwent pulmonary function tests (PFT) and lungs were harvested for volume measurement and analyses of the VEGF signaling pathway. To investigate the role of hypoxia in mediating the effects of VEGFR1, experiments were repeated with concurrent administration of PT-2385, an inhibitor of hypoxia-induced factor (HIF)2α, via orogastric gavage at 10 mg/kg every 12 hours for 4 days. We found that VEGFR1-treated mice had increased total lung capacity (P = 0.006), pulmonary compliance (P = 0.03), and post-euthanasia lung volume (P = 0.049) compared to control mice. VEGFR1 treatment increased pulmonary levels of VEGF (P = 0.008) and VEGFR2 (P = 0.01). It also stimulated endothelial proliferation (P < 0.0001) and enhanced pulmonary surfactant production (P = 0.03). The addition of PT-2385 abolished the increase in lung volume and endothelial proliferation in response to VEGFR1. By paradoxically stimulating angiogenesis and enhancing lung growth, VEGFR1 could represent a new treatment strategy for neonatal lung diseases characterized by dysfunction of the HIF-VEGF pathway. |
| format |
article |
| author |
Duy T Dao Lorenzo Anez-Bustillos Sahir S Jabbouri Amy Pan Hiroko Kishikawa Paul D Mitchell Gillian L Fell Meredith A Baker Randolph S Watnick Hong Chen Michael S Rogers Diane R Bielenberg Mark Puder |
| author_facet |
Duy T Dao Lorenzo Anez-Bustillos Sahir S Jabbouri Amy Pan Hiroko Kishikawa Paul D Mitchell Gillian L Fell Meredith A Baker Randolph S Watnick Hong Chen Michael S Rogers Diane R Bielenberg Mark Puder |
| author_sort |
Duy T Dao |
| title |
A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor. |
| title_short |
A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor. |
| title_full |
A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor. |
| title_fullStr |
A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor. |
| title_full_unstemmed |
A paradoxical method to enhance compensatory lung growth: Utilizing a VEGF inhibitor. |
| title_sort |
paradoxical method to enhance compensatory lung growth: utilizing a vegf inhibitor. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2018 |
| url |
https://doaj.org/article/1b3d0cc9fe344dfcb85c9aed00b3e2fd |
| work_keys_str_mv |
AT duytdao aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT lorenzoanezbustillos aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT sahirsjabbouri aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT amypan aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT hirokokishikawa aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT pauldmitchell aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT gillianlfell aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT meredithabaker aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT randolphswatnick aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT hongchen aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT michaelsrogers aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT dianerbielenberg aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT markpuder aparadoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT duytdao paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT lorenzoanezbustillos paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT sahirsjabbouri paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT amypan paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT hirokokishikawa paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT pauldmitchell paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT gillianlfell paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT meredithabaker paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT randolphswatnick paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT hongchen paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT michaelsrogers paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT dianerbielenberg paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor AT markpuder paradoxicalmethodtoenhancecompensatorylunggrowthutilizingavegfinhibitor |
| _version_ |
1718374211290923008 |